Last 12 months
Inside the activity.
22 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 6 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 10 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 6 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 23, 2020 Filed Nov 23, 2020 21:51 UTC |
Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, China
|
SaleCommon Stock | 2,874 | $83.14 | $238,944.36 |
DisclosureSEC source: 0001209191-20-059983 · doc4.xml · nonDerivative · entry 7 Blickensdoerfer Hans-Martin · CIK 0001488891 · Sr. VP, Comm. Ops, China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,381 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.60 to $83.71, inclusive. Read SEC document |
| November 23, 2020 Filed Nov 23, 2020 21:51 UTC |
Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, China
|
SaleCommon Stock | 1,900 | $83.02 | $157,738.00 |
DisclosureSEC source: 0001209191-20-059983 · doc4.xml · nonDerivative · entry 6 Blickensdoerfer Hans-Martin · CIK 0001488891 · Sr. VP, Comm. Ops, China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,255 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.55 to $83.40, inclusive. Read SEC document |
| November 23, 2020 Filed Nov 23, 2020 21:51 UTC |
Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, China
|
Exercise / conversionCommon Stock | 1,900 | $15.54 | $29,526.00 |
DisclosureSEC source: 0001209191-20-059983 · doc4.xml · nonDerivative · entry 5 Blickensdoerfer Hans-Martin · CIK 0001488891 · Sr. VP, Comm. Ops, China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,155 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 23, 2020 Filed Nov 25, 2020 21:08 UTC |
Francese James ESr. VP, Comm. Ops., NA, APAC
|
Exercise / conversionCommon Stock Options · Derivative | 4,144 | $0.00 Strike: $15.54 | $0.00 |
DisclosureSEC source: 0001209191-20-060495 · doc4.xml · derivative · entry 5 Francese James E · CIK 0001571478 · Sr. VP, Comm. Ops., NA, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,144 shares Expires 2024-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 23, 2020 Filed Nov 25, 2020 21:08 UTC |
Francese James ESr. VP, Comm. Ops., NA, APAC
|
Exercise / conversionCommon Stock Options · Derivative | 14,815 | $0.00 Strike: $7.35 | $0.00 |
DisclosureSEC source: 0001209191-20-060495 · doc4.xml · derivative · entry 4 Francese James E · CIK 0001571478 · Sr. VP, Comm. Ops., NA, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,185 Underlying: Common Stock · 14,815 shares Expires 2025-04-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 23, 2020 Filed Nov 25, 2020 21:08 UTC |
Francese James ESr. VP, Comm. Ops., NA, APAC
|
SaleCommon Stock | 18,959 | $80.13 | $1,519,184.67 |
DisclosureSEC source: 0001209191-20-060495 · doc4.xml · nonDerivative · entry 3 Francese James E · CIK 0001571478 · Sr. VP, Comm. Ops., NA, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,383 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.49 to $81.93, inclusive. Read SEC document |
| November 23, 2020 Filed Nov 25, 2020 21:08 UTC |
Francese James ESr. VP, Comm. Ops., NA, APAC
|
Exercise / conversionCommon Stock | 4,144 | $15.54 | $64,397.76 |
DisclosureSEC source: 0001209191-20-060495 · doc4.xml · nonDerivative · entry 2 Francese James E · CIK 0001571478 · Sr. VP, Comm. Ops., NA, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,342 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 23, 2020 Filed Nov 25, 2020 21:08 UTC |
Francese James ESr. VP, Comm. Ops., NA, APAC
|
Exercise / conversionCommon Stock | 14,815 | $7.35 | $108,890.25 |
DisclosureSEC source: 0001209191-20-060495 · doc4.xml · nonDerivative · entry 1 Francese James E · CIK 0001571478 · Sr. VP, Comm. Ops., NA, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,198 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 20, 2020 Filed Nov 23, 2020 21:51 UTC |
Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, China
|
SaleCommon Stock | 2,688 | $83.02 | $223,157.76 |
DisclosureSEC source: 0001209191-20-059983 · doc4.xml · nonDerivative · entry 4 Blickensdoerfer Hans-Martin · CIK 0001488891 · Sr. VP, Comm. Ops, China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,255 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.00 to $83.11, inclusive. Read SEC document |
| November 19, 2020 Filed Nov 23, 2020 21:51 UTC |
Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, China
|
Exercise / conversionCommon Stock Options · Derivative | 12,156 | $0.00 Strike: $15.54 | $0.00 |
DisclosureSEC source: 0001209191-20-059983 · doc4.xml · derivative · entry 8 Blickensdoerfer Hans-Martin · CIK 0001488891 · Sr. VP, Comm. Ops, China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,844 Underlying: Common Stock · 12,156 shares Expires 2024-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 19, 2020 Filed Nov 23, 2020 21:51 UTC |
Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, China
|
SaleCommon Stock | 14,007 | $82.03 | $1,148,994.21 |
DisclosureSEC source: 0001209191-20-059983 · doc4.xml · nonDerivative · entry 3 Blickensdoerfer Hans-Martin · CIK 0001488891 · Sr. VP, Comm. Ops, China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,943 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.00 to $82.32, inclusive. Read SEC document |
| November 19, 2020 Filed Nov 23, 2020 21:51 UTC |
Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, China
|
Exercise / conversionCommon Stock | 12,156 | $82.02 | $997,035.12 |
DisclosureSEC source: 0001209191-20-059983 · doc4.xml · nonDerivative · entry 2 Blickensdoerfer Hans-Martin · CIK 0001488891 · Sr. VP, Comm. Ops, China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,950 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.00 to $82.30, inclusive. Read SEC document |
| November 19, 2020 Filed Nov 23, 2020 21:51 UTC |
Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, China
|
Exercise / conversionCommon Stock | 12,156 | $15.54 | $188,904.24 |
DisclosureSEC source: 0001209191-20-059983 · doc4.xml · nonDerivative · entry 1 Blickensdoerfer Hans-Martin · CIK 0001488891 · Sr. VP, Comm. Ops, China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,106 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 16, 2020 Filed Nov 17, 2020 21:52 UTC |
Barnes Scott DChief Medical Officer
|
Exercise / conversionCommon Stock Options · Derivative | 17,163 | $0.00 Strike: $35.98 | $0.00 |
DisclosureSEC source: 0001209191-20-058748 · doc4.xml · derivative · entry 5 Barnes Scott D · CIK 0001781830 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,731 Underlying: Common Stock · 17,163 shares Expires 2029-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options granted become exercisable as follows: 1/3 on 3/14/2020 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/14/2022. Read SEC document |
| November 16, 2020 Filed Nov 17, 2020 21:52 UTC |
Barnes Scott DChief Medical Officer
|
Exercise / conversionCommon Stock Options · Derivative | 5,430 | $0.00 Strike: $29.80 | $0.00 |
DisclosureSEC source: 0001209191-20-058748 · doc4.xml · derivative · entry 4 Barnes Scott D · CIK 0001781830 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,312 Underlying: Common Stock · 5,430 shares Expires 2028-06-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options granted become exercisable as follows: 1/3 on 6/14/2019 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 6/14/2021. Read SEC document |
| November 16, 2020 Filed Nov 17, 2020 21:52 UTC |
Barnes Scott DChief Medical Officer
|
Exercise / conversionCommon Stock | 22,593 | $80.25 | $1,813,088.25 |
DisclosureSEC source: 0001209191-20-058748 · doc4.xml · nonDerivative · entry 3 Barnes Scott D · CIK 0001781830 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,390 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.58 to $81.32, inclusive. Read SEC document |
| November 16, 2020 Filed Nov 17, 2020 21:52 UTC |
Barnes Scott DChief Medical Officer
|
Exercise / conversionCommon Stock | 17,163 | $35.98 | $617,524.74 |
DisclosureSEC source: 0001209191-20-058748 · doc4.xml · nonDerivative · entry 2 Barnes Scott D · CIK 0001781830 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,983 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 16, 2020 Filed Nov 17, 2020 21:52 UTC |
Barnes Scott DChief Medical Officer
|
Exercise / conversionCommon Stock | 5,430 | $29.80 | $161,814.00 |
DisclosureSEC source: 0001209191-20-058748 · doc4.xml · nonDerivative · entry 1 Barnes Scott D · CIK 0001781830 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,820 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 21:51 UTC |
Hayashida Jon K.VP, Global Clinical, Medical
|
Exercise / conversionCommon Stock Options · Derivative | 9,800 | $0.00 Strike: $16.15 | $0.00 |
DisclosureSEC source: 0001209191-20-057990 · doc4.xml · derivative · entry 5 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 724 Underlying: Common Stock · 9,800 shares Expires 2028-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 21:51 UTC |
Hayashida Jon K.VP, Global Clinical, Medical
|
Exercise / conversionCommon Stock Options · Derivative | 10,200 | $0.00 Strike: $29.80 | $0.00 |
DisclosureSEC source: 0001209191-20-057990 · doc4.xml · derivative · entry 4 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,058 Underlying: Common Stock · 10,200 shares Expires 2028-06-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 21:51 UTC |
Hayashida Jon K.VP, Global Clinical, Medical
|
SaleCommon Stock | 20,000 | $81.34 | $1,626,800.00 |
DisclosureSEC source: 0001209191-20-057990 · doc4.xml · nonDerivative · entry 3 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,794 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.06 to $82.85, inclusive. Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 21:51 UTC |
Hayashida Jon K.VP, Global Clinical, Medical
|
Exercise / conversionCommon Stock | 9,800 | $16.15 | $158,270.00 |
DisclosureSEC source: 0001209191-20-057990 · doc4.xml · nonDerivative · entry 2 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,794 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 21:51 UTC |
Hayashida Jon K.VP, Global Clinical, Medical
|
Exercise / conversionCommon Stock | 10,200 | $29.80 | $303,960.00 |
DisclosureSEC source: 0001209191-20-057990 · doc4.xml · nonDerivative · entry 1 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,994 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 21:50 UTC |
Holliday KeithChief Technology Officer
|
Exercise / conversionCommon Stock Options · Derivative | 15,000 | $0.00 Strike: $9.30 | $0.00 |
DisclosureSEC source: 0001209191-20-057989 · doc4.xml · derivative · entry 5 Holliday Keith · CIK 0001678691 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2027-03-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 21:50 UTC |
Holliday KeithChief Technology Officer
|
Exercise / conversionCommon Stock Options · Derivative | 23,714 | $0.00 Strike: $7.52 | $0.00 |
DisclosureSEC source: 0001209191-20-057989 · doc4.xml · derivative · entry 4 Holliday Keith · CIK 0001678691 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,714 shares Expires 2026-03-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 21:50 UTC |
Holliday KeithChief Technology Officer
|
SaleCommon Stock | 23,714 | $81.56 | $1,934,113.84 |
DisclosureSEC source: 0001209191-20-057989 · doc4.xml · nonDerivative · entry 3 Holliday Keith · CIK 0001678691 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,332 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.00 to $82.85, inclusive. Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 21:50 UTC |
Holliday KeithChief Technology Officer
|
Exercise / conversionCommon Stock | 15,000 | $9.30 | $139,500.00 |
DisclosureSEC source: 0001209191-20-057989 · doc4.xml · nonDerivative · entry 2 Holliday Keith · CIK 0001678691 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,046 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 21:50 UTC |
Holliday KeithChief Technology Officer
|
Exercise / conversionCommon Stock | 23,714 | $7.52 | $178,329.28 |
DisclosureSEC source: 0001209191-20-057989 · doc4.xml · nonDerivative · entry 1 Holliday Keith · CIK 0001678691 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,046 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 21:48 UTC |
Moore John CDirector
|
Exercise / conversionCommon Stock Options · Derivative | 1,206 | $0.00 Strike: $16.15 | $0.00 |
DisclosureSEC source: 0001209191-20-057986 · doc4.xml · derivative · entry 8 Moore John C · CIK 0001426569 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,206 shares Expires 2028-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 21:48 UTC |
Moore John CDirector
|
Exercise / conversionCommon Stock Options · Derivative | 10,000 | $0.00 Strike: $15.73 | $0.00 |
DisclosureSEC source: 0001209191-20-057986 · doc4.xml · derivative · entry 7 Moore John C · CIK 0001426569 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2024-06-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 21:48 UTC |
Moore John CDirector
|
Exercise / conversionCommon Stock Options · Derivative | 5,000 | $0.00 Strike: $10.31 | $0.00 |
DisclosureSEC source: 0001209191-20-057986 · doc4.xml · derivative · entry 6 Moore John C · CIK 0001426569 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2022-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 21:48 UTC |
Moore John CDirector
|
Disposition to issuerCommon Stock | 14,254 | $80.88 | $1,152,863.52 |
DisclosureSEC source: 0001209191-20-057986 · doc4.xml · nonDerivative · entry 5 Moore John C · CIK 0001426569 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 11,387 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.00 to $81.79, inclusive. Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 21:48 UTC |
Moore John CDirector
|
Disposition to issuerCommon Stock | 16,206 | $81.03 | $1,313,172.18 |
DisclosureSEC source: 0001209191-20-057986 · doc4.xml · nonDerivative · entry 4 Moore John C · CIK 0001426569 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,117 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.00 to $82.16, inclusive. Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 21:48 UTC |
Moore John CDirector
|
Exercise / conversionCommon Stock | 1,206 | $16.15 | $19,476.90 |
DisclosureSEC source: 0001209191-20-057986 · doc4.xml · nonDerivative · entry 3 Moore John C · CIK 0001426569 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,323 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 21:48 UTC |
Moore John CDirector
|
Exercise / conversionCommon Stock | 10,000 | $15.73 | $157,300.00 |
DisclosureSEC source: 0001209191-20-057986 · doc4.xml · nonDerivative · entry 2 Moore John C · CIK 0001426569 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,117 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 21:48 UTC |
Moore John CDirector
|
Exercise / conversionCommon Stock | 5,000 | $10.31 | $51,550.00 |
DisclosureSEC source: 0001209191-20-057986 · doc4.xml · nonDerivative · entry 1 Moore John C · CIK 0001426569 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,117 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2020 Filed Sep 16, 2020 22:01 UTC |
Holliday KeithChief Technology Officer
|
Exercise / conversionCommon Stock Options · Derivative | 12,997 | $0.00 Strike: $35.98 | $0.00 |
DisclosureSEC source: 0001209191-20-050755 · doc4.xml · derivative · entry 15 Holliday Keith · CIK 0001678691 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,998 Underlying: Common Stock · 12,997 shares Expires 2029-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The options granted become exercisable as follows: 1/3 on 3/14/2020 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/14/2022. Read SEC document |
| September 15, 2020 Filed Sep 16, 2020 22:01 UTC |
Holliday KeithChief Technology Officer
|
Exercise / conversionCommon Stock Options · Derivative | 10,112 | $0.00 Strike: $29.80 | $0.00 |
DisclosureSEC source: 0001209191-20-050755 · doc4.xml · derivative · entry 14 Holliday Keith · CIK 0001678691 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,372 Underlying: Common Stock · 10,112 shares Expires 2028-06-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The options granted become exercisable as follows: 1/3 on 6/14/2019 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 6/14/2021. Read SEC document |
| September 15, 2020 Filed Sep 16, 2020 22:01 UTC |
Holliday KeithChief Technology Officer
|
Exercise / conversionCommon Stock Options · Derivative | 13,217 | $0.00 Strike: $16.15 | $0.00 |
DisclosureSEC source: 0001209191-20-050755 · doc4.xml · derivative · entry 13 Holliday Keith · CIK 0001678691 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,789 Underlying: Common Stock · 13,217 shares Expires 2028-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The options granted become exercisable as follows: 1/3 on 3/15/2019 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/15/2021. Read SEC document |
| September 15, 2020 Filed Sep 16, 2020 22:01 UTC |
Holliday KeithChief Technology Officer
|
SaleCommon Stock | 36,326 | $53.33 | $1,937,265.58 |
DisclosureSEC source: 0001209191-20-050755 · doc4.xml · nonDerivative · entry 9 Holliday Keith · CIK 0001678691 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,332 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.02 to $53.71, inclusive. Read SEC document |
| September 15, 2020 Filed Sep 16, 2020 22:01 UTC |
Holliday KeithChief Technology Officer
|
Exercise / conversionCommon Stock | 12,997 | $35.98 | $467,632.06 |
DisclosureSEC source: 0001209191-20-050755 · doc4.xml · nonDerivative · entry 8 Holliday Keith · CIK 0001678691 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,658 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2020 Filed Sep 16, 2020 22:01 UTC |
Holliday KeithChief Technology Officer
|
Exercise / conversionCommon Stock | 10,112 | $29.80 | $301,337.60 |
DisclosureSEC source: 0001209191-20-050755 · doc4.xml · nonDerivative · entry 7 Holliday Keith · CIK 0001678691 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,661 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2020 Filed Sep 16, 2020 22:01 UTC |
Holliday KeithChief Technology Officer
|
Exercise / conversionCommon Stock | 13,217 | $16.15 | $213,454.55 |
DisclosureSEC source: 0001209191-20-050755 · doc4.xml · nonDerivative · entry 6 Holliday Keith · CIK 0001678691 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,549 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 14, 2020 Filed Sep 16, 2020 22:01 UTC |
Holliday KeithChief Technology Officer
|
Exercise / conversionCommon Stock Options · Derivative | 3,994 | $0.00 Strike: $16.15 | $0.00 |
DisclosureSEC source: 0001209191-20-050755 · doc4.xml · derivative · entry 12 Holliday Keith · CIK 0001678691 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,006 Underlying: Common Stock · 3,994 shares Expires 2028-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The options granted become exercisable as follows: 1/3 on 3/15/2019 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/15/2021. Read SEC document |
| September 14, 2020 Filed Sep 16, 2020 22:01 UTC |
Holliday KeithChief Technology Officer
|
Exercise / conversionCommon Stock Options · Derivative | 21,294 | $0.00 Strike: $9.30 | $0.00 |
DisclosureSEC source: 0001209191-20-050755 · doc4.xml · derivative · entry 11 Holliday Keith · CIK 0001678691 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,206 Underlying: Common Stock · 21,294 shares Expires 2027-03-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 14, 2020 Filed Sep 16, 2020 22:01 UTC |
Holliday KeithChief Technology Officer
|
Exercise / conversionCommon Stock Options · Derivative | 1,286 | $0.00 Strike: $7.52 | $0.00 |
DisclosureSEC source: 0001209191-20-050755 · doc4.xml · derivative · entry 10 Holliday Keith · CIK 0001678691 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,714 Underlying: Common Stock · 1,286 shares Expires 2026-03-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 14, 2020 Filed Sep 16, 2020 22:01 UTC |
Holliday KeithChief Technology Officer
|
SaleCommon Stock | 9,115 | $53.49 | $487,561.35 |
DisclosureSEC source: 0001209191-20-050755 · doc4.xml · nonDerivative · entry 5 Holliday Keith · CIK 0001678691 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,332 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.25 to $54.06, inclusive. Read SEC document |
| September 14, 2020 Filed Sep 16, 2020 22:01 UTC |
Holliday KeithChief Technology Officer
|
SaleCommon Stock | 26,574 | $53.26 | $1,415,331.24 |
DisclosureSEC source: 0001209191-20-050755 · doc4.xml · nonDerivative · entry 4 Holliday Keith · CIK 0001678691 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,447 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.07 to $53.97, inclusive. Read SEC document |
| September 14, 2020 Filed Sep 16, 2020 22:01 UTC |
Holliday KeithChief Technology Officer
|
Exercise / conversionCommon Stock | 3,994 | $16.15 | $64,503.10 |
DisclosureSEC source: 0001209191-20-050755 · doc4.xml · nonDerivative · entry 3 Holliday Keith · CIK 0001678691 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,021 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 14, 2020 Filed Sep 16, 2020 22:01 UTC |
Holliday KeithChief Technology Officer
|
Exercise / conversionCommon Stock | 21,294 | $9.30 | $198,034.20 |
DisclosureSEC source: 0001209191-20-050755 · doc4.xml · nonDerivative · entry 2 Holliday Keith · CIK 0001678691 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,027 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.